Skip to main content
. 2020 Aug 12;21(16):5783. doi: 10.3390/ijms21165783

Table 1.

Bioaction of MaR1, RvD1, and NPD1.

SPMs Receptor Bioaction in AD Reference
MaR1 LGR6 Promote microglial phagocytosis of Aβ
Promote tissue regeneration
Analgesic effect
[50,111,113]
RvD1 ALX/FPR2 & GPR32 Enhance tissue remodeling in microglia
Promote macrophage phagocytosis of Aβ
[117,118,119]
NPD1 GPR37 Influence cell survival, neuroinflammatory signaling and transcription
Suppress the production of APP
[51,120,121]